Whole-genome sequencing (WGS) enables faster identification of disease-causing genetic abnormalities in infants improving clinical care and management SAN DIEGO, Oct. 27, 2021 /PRNewswire/
/PRNewswire/ Illumina, Inc. (NASDAQ: ILMN) today announced an agreement with Israel s Ministry of Health (MoH) for a pilot program to implement the use of.